Ro 20-1724: An Agent that Significantly Improves Psoriatic Lesions in Double-Blind Clinical Trials
- 1 October 1979
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 73 (4), 261-263
- https://doi.org/10.1111/1523-1747.ep12531617
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Papaverine and Ro 20-1724 Inhibit Cyclic Nucleotide Phosphodiesterase Activity and Increase Cyclic AMP Levels in Psoriatic Epidermis In VitroJournal of Investigative Dermatology, 1978
- Cyclic Amp And PsoriasisJournal of Investigative Dermatology, 1975
- Micro-determination of cyclic AMP levels in human epidermis, dermis and hair folliclesBritish Journal of Dermatology, 1975
- Papaverine: Its Effects on Cyclic Amp in Vitro and Psoriasis in VivoJournal of Investigative Dermatology, 1975
- Cyclic adenosine monophosphate, adenyl cyclase and cyclic nucleotide phosphodiesterase in psoriatic epidermis, with a comment on urinary cAMPActa Dermato-Venereologica, 1974
- Increased cyclic GMP and decreased cyclic AMP levels in the hyperplastic, abnormally differentiated epidermis of psoriasisLife Sciences, 1973
- Decreased Cyclic AMP in the Epidermis of Lesions of PsoriasisArchives of Dermatology, 1972